Medicare Enrolled
Dr. Daniel Delo, MD
Rheumatology · Wilmington, NC
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Delo from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Delo?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Delo
Dr. Daniel Delo is a rheumatology specialist in Wilmington, NC, with 19 years of NPI registration. Based on federal Medicare data, Dr. Delo performed 223,261 Medicare services across 3,996 unique beneficiaries.
Between the years covered by Open Payments, Dr. Delo received a total of $4,871 from 29 pharmaceutical and/or device companies across 163 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Delo is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 5% volume in NC
$4,871 industry payments
Medicare Practice Summary
Medicare Utilization ↗223,261
Medicare services
Top 5% in NC for rheumatology
3,996
Unique beneficiaries
$13
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~11,751 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Tocilizumab injection (Actemra) | 79,040 | $5 | $7 |
| Golimumab infusion (Simponi Aria) Administration of golimumab medication directly into a vein. This code specifies the dosage amount of 1 milligram for intravenous delivery. |
38,622 | $11 | $45 |
| Certolizumab injection (Cimzia) An injection of certolizumab pegol administered under the direct supervision of a physician. |
34,800 | $4 | $18 |
| Abatacept infusion (Orencia) An injection of abatacept administered under the direct supervision of a physician. This code is used for Medicare when the drug is not self-administered. |
34,000 | $34 | $80 |
| Romosozumab injection (Evenity) for osteoporosis | 13,020 | $8 | $14 |
| Infliximab infusion (Remicade) An injection of infliximab, excluding biosimilar versions, administered in a 10 mg dose. |
5,760 | $26 | $138 |
| Denosumab injection (Prolia/Xgeva) | 5,160 | $18 | $30 |
| Infliximab-abda biosimilar injection, 10 mg This code represents the administration of a 10 mg dose of infliximab-abda, a biosimilar medication. It covers the injection of this specific pharmaceutical product. |
2,930 | $29 | $83 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,170 | $90 | $150 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
1,116 | $8 | $21 |
| C-reactive protein test (inflammation marker) A blood test that measures the level of C-reactive protein to detect the presence of infection or inflammation in the body. |
1,102 | $5 | $45 |
| Blood creatinine level test A blood test that measures the amount of creatinine, a waste product from muscle wear and tear, to help assess kidney function. |
1,085 | $5 | $21 |
| Liver function blood test panel | 1,067 | $8 | $60 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
943 | $98 | $330 |
| Autoimmune disorder antibody test A laboratory test that measures antibodies in the blood to help assess for autoimmune disorders. |
511 | $18 | $35 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
436 | $7 | $7 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
319 | $55 | $120 |
| Phosphate level test A blood test that measures the amount of phosphate in your body. Phosphate is a mineral that helps keep bones and teeth strong. |
160 | $5 | $20 |
| Parathyroid hormone level test A blood test that measures the amount of parathyroid hormone in your body. This hormone helps regulate calcium levels in the blood and bones. |
158 | $40 | $85 |
| Tuberculosis test, enumeration of t-cells A blood test that counts T-cells to help detect tuberculosis infection. |
148 | $98 | $125 |
| Total calcium level test A blood test that measures the total amount of calcium in your body. |
144 | $5 | $21 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
144 | $21 | $50 |
| Vitamin D level test A blood test to measure the amount of Vitamin D-3 in your body. |
142 | $29 | $63 |
| Complete ultrasound scan of joint An ultrasound exam that uses sound waves to create detailed images of a joint. This procedure allows for the visualization of the joint's internal structures. |
108 | $8 | $200 |
| Measurement of dna antibody, single stranded | 105 | $12 | $30 |
| DNA antibody test (native or double-stranded) A blood test that measures the level of antibodies targeting native or double-stranded DNA. This test is used to detect the presence of these specific antibodies in the body. |
104 | $13 | $30 |
| Bone density scan (DEXA) A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures. |
100 | $36 | $150 |
| Complement and antigen measurement A laboratory test to measure levels of complement proteins and antigens in the blood. |
83 | $12 | $55 |
| Complement function test A blood test that measures the activity of complement proteins, which are part of the immune system. |
82 | $12 | $55 |
| Immunoassay substance analysis, multiple step method A laboratory test that uses an immunoassay technique to analyze a substance. The process involves multiple steps to detect or measure the target material. |
58 | $11 | $50 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
57 | $44 | $125 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
55 | $10 | $50 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
52 | $133 | $180 |
| Methylprednisolone acetate injection, 80 mg An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication. |
49 | $9 | $20 |
| Uric acid level test A blood test that measures the level of uric acid in your body. Uric acid is a waste product formed when the body breaks down purines. |
45 | $4 | $20 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
42 | $12 | $65 |
| X-ray of hand, minimum of 3 views An X-ray imaging test of the hand that captures at least three different angles to visualize the bones and joints. |
37 | $20 | $72 |
| New patient office visit, complex (60-74 min) | 32 | $150 | $285 |
| Rheumatoid factor level | 29 | $5 | $12 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
28 | $57 | $95 |
| X-ray of lower and sacral spine, minimum of 4 views An X-ray imaging test of the lower back and sacrum using at least four different angles to visualize the bones and joints. |
26 | $27 | $106 |
| Rheumatoid arthritis antibody test A blood test to measure antibodies used in assessing rheumatoid arthritis. |
26 | $12 | $28 |
| Shoulder X-ray, 2+ views An X-ray imaging test of the shoulder joint using at least two different angles to visualize the bones and surrounding structures. |
25 | $20 | $55 |
| Methylprednisolone injection, up to 40 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, administered in a dose of up to 40 mg. |
25 | $3 | $40 |
| Joint fluid aspiration or injection, medium joint Removal of fluid from a medium-sized joint or injection of medication into the joint space. |
20 | $39 | $105 |
| Hip X-ray, 2-3 views An X-ray imaging test of the hip joint using two to three different angles to visualize the bones and surrounding structures. |
19 | $27 | $85 |
| Knee X-ray, 3 views An X-ray imaging test of the knee joint that captures three different angles to evaluate the bones and surrounding structures. |
19 | $24 | $72 |
| Cardiac enzyme level (CK-MB) test A blood test that measures the total level of creatine kinase, specifically the cardiac enzyme fraction, to help evaluate heart muscle damage. |
17 | $6 | $26 |
| X-ray of sacroiliac joint, 3 or more views An X-ray imaging test that takes three or more pictures of the joint connecting the lower spine to the hip bone. |
15 | $22 | $86 |
| Autoimmune disorder screening test A laboratory test used to screen for the presence of autoimmune disorders. |
15 | $12 | $30 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
11 | $15 | $57 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
35.5% high complexity
60.8% medium
3.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$4,871
Total received (2018-2024)
Avg $696/year across 7 years
Top 44% in NC for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
29
Companies
163
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,871 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$447
2023
$2,004
2022
$44
2021
$959
2020
$237
2019
$541
2018
$639
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$83
Amgen Inc.
$73
ABBVIE INC.
$70
UCB, Inc.
$41
AstraZeneca Pharmaceuticals LP
$38
Novartis Pharmaceuticals Corporation
$26
Sandoz Inc.
$23
Fresenius Kabi USA, LLC
$23
Lilly USA, LLC
$19
Boehringer Ingelheim Pharmaceuticals, Inc.
$18
Aurinia Pharma U.S., Inc.
$16
E.R. Squibb & Sons, L.L.C.
$16
Top 3 companies account for 50.5% of 2024 payments
All-time payments by company (2018-2024) ›
Biogen, Inc.
$1,607
Amgen Inc.
$729
AbbVie, Inc.
$329
Boehringer Ingelheim Pharmaceuticals, Inc.
$255
Genentech USA, Inc.
$237
Janssen Biotech, Inc.
$224
UCB, Inc.
$181
Radius Health, Inc.
$156
GlaxoSmithKline, LLC.
$149
E.R. Squibb & Sons, L.L.C.
$130
AstraZeneca Pharmaceuticals LP
$97
AbbVie Inc.
$93
Novartis Pharmaceuticals Corporation
$79
Lilly USA, LLC
$76
ABBVIE INC.
$70
PFIZER INC.
$66
Aurinia Pharma U.S., Inc.
$53
Regeneron Healthcare Solutions, Inc.
$47
Horizon Therapeutics plc
$47
Fresenius Kabi USA, LLC
$44
Sandoz Inc.
$40
Celgene Corporation
$31
Actelion Pharmaceuticals US, Inc.
$26
Mallinckrodt Hospital Products Inc.
$20
SOBI, INC
$19
Ultragenyx Pharmaceutical Inc.
$18
Organon LLC
$18
Bioventus LLC
$16
Merck Sharp & Dohme Corporation
$14
Top 3 companies account for 54.7% of all-time payments
Associated products mentioned in payments ›
ACTHAR · Actemra · BENLYSTA · Bimzelx · COSENTYX · CYLTEZO · Cimzia · Crysvita · Durolane · EVENITY · Enbrel · FORTEO · HADLIMA · HYRIMOZ · Humira · IDACIO · KEVZARA · KRYSTEXXA · Kineret · LUPKYNIS · OFEV · OPSUMIT · ORENCIA · Otezla · Prolia · RINVOQ · Rinvoq · Rituxan · SAPHNELO · SIMPONI ARIA · SKYRIZI · TALTZ · TAVNEOS · TREMFYA · Tymlos · XELJANZ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Rheumatologists within 10 mi
12
Per 100K population
5.2
County median income
$72,892
Nearest hospital
WILMINGTON TREATMENT CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Delo is a mixed practice specialist, with above-average Medicare volume (top 5% in NC), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Delo experienced with tocilizumab injection (actemra)?
Based on Medicare claims data, Dr. Delo performed 79,040 tocilizumab injection (actemra) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Delo receive payments from pharmaceutical companies?
Yes. Dr. Delo received a total of $4,871 from 29 companies across 163 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Delo's costs compare to other rheumatologists in Wilmington?
Dr. Delo's average Medicare payment per service is $13. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Delo) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Rheumatologists in Wilmington
Browse rheumatologists in Wilmington ranked by procedure volume and transparency data.
Highest volume
Top Rheumatologists in NC
Rheumatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Rheumatologists in NC
Which NC rheumatologists receive the most from drug and device companies.
By company
Biogen, Inc. Payments to Doctors
See all physicians who received payments from Biogen, Inc.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
AbbVie, Inc. Payments to Doctors
See all physicians who received payments from AbbVie, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology